Beneficial effects of empagliflozin on hematocrit levels in a patient with severe anemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2008-2231
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Beneficial effects of empagliflozin on hematocrit levels in a patient with severe anemia ; volume:29 ; number:2 ; day:21 ; month:9 ; year:2021 ; pages:507-510 ; date:12.2021
DARU ; 29, Heft 2 (21.9.2021), 507-510, 12.2021
- Creator
-
Budzianowski, Jan
Rzeźniczak, Janusz
Hiczkiewicz, Jarosław
Kasprzak, Dominika
Winnicka-Zielińska, Anna
Musielak, Bogdan
Pieszko, Konrad
Burchardt, Paweł
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40199-021-00417-5
- URN
-
urn:nbn:de:101:1-2022012819213320862195
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Budzianowski, Jan
- Rzeźniczak, Janusz
- Hiczkiewicz, Jarosław
- Kasprzak, Dominika
- Winnicka-Zielińska, Anna
- Musielak, Bogdan
- Pieszko, Konrad
- Burchardt, Paweł
- SpringerLink (Online service)
Other Objects (12)
Anemia in Patients with Severe Aortic Stenosis
Fetal NT-proBNP levels and their course in severe anemia during intrauterine treatment
Biochemical and histopathological evidence for beneficial effects of Empagliflozin pretreatment on acetic acid-induced colitis in rats
Empagliflozin reduces interleukin-6 levels in patients with heart failure
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Highly beneficial outcome in severe acute necrotizing encephalopathy with tocilizumab treatment
Entire expressed peripheral blood transcriptome in pediatric severe malarial anemia
Anemia in severe heart failure patients: does it predict prognosis?
Anti-inflammatory potential of Empagliflozin
Empagliflozin: a potential anticancer drug
Celiac Disease in Children with Moderate-to-Severe Iron-deficiency Anemia
Resolvin E1 improves efferocytosis and rescues severe aplastic anemia in mice
Anemia in Patients with Severe Aortic Stenosis
Fetal NT-proBNP levels and their course in severe anemia during intrauterine treatment
Biochemical and histopathological evidence for beneficial effects of Empagliflozin pretreatment on acetic acid-induced colitis in rats
Empagliflozin reduces interleukin-6 levels in patients with heart failure
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Highly beneficial outcome in severe acute necrotizing encephalopathy with tocilizumab treatment
Entire expressed peripheral blood transcriptome in pediatric severe malarial anemia
Anemia in severe heart failure patients: does it predict prognosis?
Anti-inflammatory potential of Empagliflozin
Empagliflozin: a potential anticancer drug
Celiac Disease in Children with Moderate-to-Severe Iron-deficiency Anemia
Resolvin E1 improves efferocytosis and rescues severe aplastic anemia in mice
Anemia in Patients with Severe Aortic Stenosis
Fetal NT-proBNP levels and their course in severe anemia during intrauterine treatment
Biochemical and histopathological evidence for beneficial effects of Empagliflozin pretreatment on acetic acid-induced colitis in rats
Empagliflozin reduces interleukin-6 levels in patients with heart failure
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Highly beneficial outcome in severe acute necrotizing encephalopathy with tocilizumab treatment
Entire expressed peripheral blood transcriptome in pediatric severe malarial anemia
Anemia in severe heart failure patients: does it predict prognosis?
Anti-inflammatory potential of Empagliflozin
Empagliflozin: a potential anticancer drug
Celiac Disease in Children with Moderate-to-Severe Iron-deficiency Anemia